Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.86
-0.0050-0.27%
Volume:1.56M
Turnover:2.89M
Market Cap:69.42M
PE:-1.26
High:1.89
Open:1.84
Low:1.83
Close:1.86
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:0.30
T/O Rate:8.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.61
PE(LYR):-1.38

Loading ...

Mar 22, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 31, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 23, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 20, 2023

Major Issues Report

8-K - Current report
Jan 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 04, 2023

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 11, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Major Issues Report

8-K - Current report